Lucilla Crudele
Overview
Explore the profile of Lucilla Crudele including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vozza A, Volpe S, Custodero C, Colaianni V, Lavarra V, Triggiani D, et al.
J Diabetes Res
. 2025 Feb;
2025:8182211.
PMID: 39963363
Diabetic kidney disease (DKD) is one of the most life-threatening complications of diabetes and a leading cause of chronic kidney disease. Glucagon-like peptide 1 receptor agonists (GLP1-RAs) or sodium-glucose cotransporter...
2.
Florio M, Crudele L, Sallustio F, Moschetta A, Cariello M, Gadaleta R
Mol Aspects Med
. 2025 Feb;
102:101349.
PMID: 39922085
Inflammatory Bowel Disease (IBD) is a set of chronic intestinal inflammatory disorders affecting the gastrointestinal (GI) tract. Beside compromised intestinal barrier function and immune hyperactivation, a common IBD feature is...
3.
De Matteis C, Crudele L, Di Buduo E, Cantatore S, Gadaleta R, Cariello M, et al.
Eur J Intern Med
. 2024 Oct;
131:49-57.
PMID: 39482164
Background And Aims: Homocysteine (Hcy) levels are elevated in different conditions, including cardiovascular diseases (CVD), diabetes, and metabolic-associated steatotic liver disease (MASLD). In this observational retrospective study, we analyzed Hcy...
4.
Crudele L, De Matteis C, Novielli F, Di Buduo E, Petruzzelli S, De Giorgi A, et al.
Biol Sex Differ
. 2024 May;
15(1):43.
PMID: 38760802
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is defined by the presence of hepatic steatosis, detected on ultrasonography (US) imaging or histology, and at least one of criteria for Metabolic...
5.
Crudele L, De Matteis C, Novielli F, Petruzzelli S, Di Buduo E, Graziano G, et al.
Intern Emerg Med
. 2024 Apr;
19(5):1267-1277.
PMID: 38668822
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) represents the hepatic manifestation of increased adiposopathy, whose pathogenetic features have been proposed as tumourigenic triggers for colorectal cancer (CRC). We aim to...
6.
Rizzi L, Coppola C, Hbaidi Y, Russo R, Crudele L, Moschetta A, et al.
Intern Emerg Med
. 2024 Apr;
19(5):1313-1321.
PMID: 38656732
Sarcoidosis is a rare granulomatous disease that can affect any organ. It leads to an increased risk of metabolic syndrome and insulin resistance, due to biochemical pathways involved in low-grade...
7.
De Matteis C, Crudele L, Gadaleta R, Di Buduo E, Novielli F, Petruzzelli S, et al.
Nutrients
. 2024 Mar;
16(5).
PMID: 38474758
Gastrointestinal (GI) cancers are one of the most relevant causes of death globally, frequently associated with poor dietary patterns. The Mediterranean Diet (MedDiet) contributes to cancer prevention. To assess adherence...
8.
Crudele L, Novielli F, De Matteis C, Petruzzelli S, Suppressa P, Berardi E, et al.
Front Oncol
. 2023 Nov;
13:1233083.
PMID: 37965446
Introduction: Thyroid cancer incidence is increasing, and adiposity-related conditions are gaining space in its pathogenesis. In this study, we aimed to detect any anthropometric, biohumoral, and clinical features that might...
9.
Crudele L, De Matteis C, Graziano G, Novielli F, Petruzzelli S, Piccinin E, et al.
Sci Rep
. 2023 Oct;
13(1):17793.
PMID: 37852989
Non-alcoholic fatty liver disease (NAFLD), specifically liver steatosis and fibrosis with steatohepatitis (NASH), is often associated with visceral adiposopathy, whose pathogenetic features have been proposed as tumorigenic triggers. We performed...
10.
Crudele L, Gadaleta R, Cariello M, Moschetta A
EBioMedicine
. 2023 Oct;
97:104821.
PMID: 37804567
The gut-liver axis plays a prominent role in the pathogenesis and therapy of metabolic diseases such as diabetes. The intestinal specific origin of several hormones that guide both inter- and...